all report title image
  • Published On : Mar 2022
  • Code : CMI4980
  • Industry : Biotechnology
  • Pages : 198
  • Formats :

COVID-19 sample collection kits are used for diagnosis and detecting SARS-CoV2 virus infection. The collection kits include vital reagents provided for collecting samples and delivering them to the laboratory where the testing services will be performed on such samples. Rising demand for COVID-19 sample collection kits as a result of the COVID-19 pandemic as well as government approval of new and enhanced detection tests are likely to propel the COVID-19 sample collection kits market growth over the forecast period. There are various types of kits available for diagnosing COVID-19, such as rapid antigen test and swabs collection kit for RT-PCR test. With the application of COVID-19 sample collection kit, the detection of virus in symptomatic patients can help in reducing the spread of the viral infection.

The global COVID-19 sample collection kits market is estimated to be valued at US$ 12.0 billion in 2021 and expected to exhibit a CAGR of 4.1% during the forecast period (2021-2028).

Figure 1. Global COVID-19 Sample Collection Kits Market in Terms of Value (US$ Billion), By Region, 2021

COVID-19 Sample Collection Kits  | Coherent Market Insights

Key market players are focusing on launching new products which are used for COVID-19 sample collection, which is expected to drive the growth of the global COVID-19 sample collection kits market during the forecast period.

Major market players are focused on launching new products in the market for COVID-19 sample collection. For instance, on December 24, 2020, EKF Diagnostics, a manufacturing company of point-of-care and central lab devices and chemistry reagents launched PrimeStore MTM, a pathogenic sample collection and transportation kit. The kit enables the collection, transportation, and handling of pathogenic samples such as COVID-19 and influenza. The kit is ideal for home-use or on-site mass sample collection for COVID-19 sample collection. In addition, the company has decided to increase its manufacturing capacity in the U.K. and Europe due to increasing demand for sample collection kits.

CMI table icon

COVID-19 Sample Collection Kits Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021:

US$ 12.0 Bn

Historical Data for: 2018 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 4.1 % 2028 Value Projection:

US$ 15.9 Bn

Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Swabs (Nasal swab, Nasopharyngeal swab, Oropharyngeal swab), Viral Transport Media, Others
  • By Application: Diagnostic, Research
  • By End User: Hospital and Clinics, COVID-19 Testing Centers, Others
Companies covered:

MyLab Discovery Solutions, Bhat Bio-Tech, Camtech Diagnostics, Angstrom Biotech Pvt. Ltd., Medsource Ozone Biomedicals Pvt Ltd., Neuromics, Oscar Medicare Pvt. Ltd., GenBody Inc., Alimetrix, Binx Health, Clinical Enterprise, Bio-Rad Laboratories, Ethos Laboratories, GetMyDNA, Kroger, LabCorp, RapidRona, EKF Diagnostics, Everlywell, Inc., and Copan Diagnostics

Growth Drivers:
  • Increasing product launch by market players
  • Increasing product approval by regulatory authorities
Restraints & Challenges:
  • Product recall

Figure 2. Global COVID-19 Sample Collection Kits Market Share (%), By Product Type, 2021

COVID-19 Sample Collection Kits  | Coherent Market Insights

Increasing product approval by regulatory authorities is projected to propel the global COVID-19 sample collection kits market growth during the forecast period.

Key market players are focusing on receiving approval for products from regulatory authorities, which is expected to propel the market growth. For instance, on December 24, 2021, Roche, a healthcare company, had received Emergency Use Authorization (EUA) approval from the U.S. Food and Drug Administration (FDA) for COVID-19 Home Test. According to the company, the test kit produces accurate, reliable, and quick results in around 20 minutes for SARS-CoV-2 and all known variants of concern, including Omicron.

Global COVID-19 Sample Collection Kits Market – Impact of Coronavirus (COVID-19) Pandemic

Following the outbreak of the COVID-19 in December 2019, the disease has spread to over 100 countries and the World Health Organization (WHO) had declared it a public health emergency. Till January 2022, according to the WHO’s report, the manifestation of coronavirus (COVID-19) has resulted in more than 293 billion infected individuals globally.

Moreover, the surging cases of COVID-19 have prompted the need for rapid testing methods to distinguish COVID-19. Hence, medical services across the world are focusing on the diagnosis of COVID-19 by collecting samples from suspected individuals. For instance, on June 26, 2021, the Indian Council of Medical Research (ICMR) provided statistics on 400 million COVID-19 sample testing completed in India. Hence, the growing concern of new variants of COVID-19 is likely to propel the market growth over the forecast period.

Global COVID-19 Sample Collection Kits Market: Restraint

Product recall for COVID-19 sample collection kits by market players or regulatory authorities is expected to hamper the growth of the global COVID-19 sample collection kits market. For instance, on April 17, 2020, the Washington State Department of Health had issued a notice for the University Of Washington School Of Medicine (UW Medicine) to stop using a batch of COVID-19 specimen collecting kits that were obtained and thought to have a quality control issue. As a result, the Department of Health issued a recall for about 12,000 kits distributed to local health jurisdictions, tribal nations, and state agency partners across the United States.

Key Players                                                               

Major players operating in the global COVID-19 sample collection kits market include MyLab Discovery Solutions, Bhat Bio-Tech, Camtech Diagnostics, Angstrom Biotech Pvt. Ltd., Medsource Ozone Biomedicals Pvt Ltd., Neuromics, Oscar Medicare Pvt. Ltd., GenBody Inc., Alimetrix, Binx Health, Clinical Enterprise, Bio-Rad Laboratories, Ethos Laboratories, GetMyDNA, Kroger, LabCorp, RapidRona, EKF Diagnostics, Everlywell, Inc., and Copan Diagnostics.

Coronavirus disease is a contagious disease caused by severe acute respiratory syndrome (SARS-CoV-2). COVID-19 sample collection kits are the kits that consist of reagents and consumables for facilitating the detection and diagnosis of SARS-Cov2 infection from nasal, nasopharyngeal, or oropharyngeal samples. The results obtained from the test are used for the identification of SARS-CoV-2. During the acute phase of infection, SARS-CoV-2 RNA is frequently detectable in respiratory specimens. The U.S. Food and Drug Administration (U.S FDA) had approved several COVID-19 sample collection kits, including home collection kits, point of care, pooling, at-home test and multi-analyte for conducting  antigen test, molecular test and antibody test, which aid in the detection of SARS-CoV2 infection.

Market Dynamics

Increasing cases of COVID-19 is expected to fuel the global COVID-19 sample collection kits market growth during the forecast period. For instance, in May 2021, according to the United States International Trade Commission (USITC), a rise in the demand for COVID-19 sample collection kits is due to the increasing spread of COVID-19. The published white paper addressed the report that examined the situation of the domestic market for swabs, viral transport medium, RNA extraction kits, serology consumables, diagnostic reagents, plastic consumables, and diagnostic tools. According to USITC, approximately 363 million COVID-19 tests were completed in the U.S. till March 7, 2021.

Key features of the study:

  • This report provides an in-depth analysis of the global COVID-19 sample collection kits market, market size (US$ Bn), and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global COVID-19 sample collection kits market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, strategies
  • Key companies covered as a part of this study include MyLab Discovery Solutions, Bhat Bio-Tech, Camtech Diagnostics, Angstrom Biotech Pvt. Ltd., Medsource Ozone Biomedicals Pvt. Ltd., Neuromics, Oscar Medicare Pvt. Ltd., GenBody Inc., Alimetrix, Binx Health, Clinical Enterprise, Bio-Rad Laboratories, Ethos Laboratories, GetMyDNA, Kroger, LabCorp, RapidRona, EKF Diagnostics, Everlywell, Inc., and Copan Diagnostics.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global COVID-19 sample collection kits market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global COVID-19 sample collection kits market

Detailed Segmentation:

  • Global COVID-19 Sample Collection Kits Market, By Product Type:
    • Swabs
      • Nasal swab
      • Nasopharyngeal swab 
      • Oropharyngeal swab
    • Viral Transport Media
    • Others
  • Global COVID-19 Sample Collection Kits Market, By Application:
    • Diagnostic
    • Research
  • Global COVID-19 Sample Collection Kits Market, By End User:
    • Hospital and Clinics
    • COVID-19 Testing Centers
    • Others
  • Global COVID-19 Sample Collection Kits Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • MyLab Discovery Solutions *
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Bhat Bio-Tech
    • Camtech Diagnostics
    • Angstrom Biotech Pvt. Ltd.
    • Medsource Ozone Biomedicals Pvt. Ltd.
    • Neuromics
    • Oscar Medicare Pvt. Ltd.
    • GenBody Inc.
    • Alimetrix
    • Binx Health
    • Clinical Enterprise
    • Bio-Rad Laboratories
    • Ethos Laboratories
    • GetMyDNA
    • Kroger
    • LabCorp
    • RapidRona
    • EKF Diagnostics
    • Everlywell, Inc.
    • Copan Diagnostics

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global COVID-19 sample collection kits market is estimated to be valued at US$ 12.0 billion in 2021 and expected to exhibit a CAGR of 4.1 % between 2021 and 2028.
Increasing cases of COVID-19 and adoption of inorganic strategies such as collaborations, partnerships, and agreements by market players are the major factors which are expected to drive the market growth during the forecast period.
The swabs segment holds a major market share in the product type segment.
The major factor hampering the market growth include the product recall.
Major players operating in the market include MyLab Discovery Solutions, Bhat Bio-Tech, Camtech Diagnostics, Angstrom Biotech Pvt. Ltd., Medsource Ozone Biomedicals Pvt Ltd., Neuromics, Oscar Medicare Pvt. Ltd., GenBody Inc., Alimetrix, Binx Health, Clinical Enterprise, Bio-Rad Laboratories, Ethos Laboratories, GetMyDNA, Kroger, LabCorp, RapidRona, EKF Diagnostics, Everlywell, Inc., and Copan Diagnostics.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo